Status:
UNKNOWN
Observational Study for Patients With Hypertrophic Cardiomyopathy
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
HCM - Hypertrophic Cardiomyopathy
Eligibility:
All Genders
Brief Summary
Observational study on patients with hypertrophic cardiomyopathy aims to investigate the correlation between cardiac fibrosis, as indicated by cardiac magnetic resonance, and the prognosis, and furthe...
Detailed Description
In this observational study on patients with hypertrophic cardiomyopathy, 500 eligible patients, who were diagnosed as hypertrophic cardiomyopathy by echocardiography, will be recruited with a median ...
Eligibility Criteria
Inclusion
- Patients diagnosed with hypertrophic cardiomyopathy by medical history, physical examination and echocardiography.
Exclusion
- Patients with cardiac hypertrophy caused by other factors such as hypertension, diabetes, myocardial amyloidosis, mitochondria cardiomyopathy, congenital heart disease, valvular heart disease, etc; Patients who had underwent heart transplatation; Individuals not suitable for the present study due to maligant tumor or severe trauma will be excluded.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04851652
Start Date
June 1 2021
End Date
December 31 2025
Last Update
April 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong cardiovascular institute
Guangzhou, Guangdong, China, 510080